{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:21:07Z","timestamp":1788524467673,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lindis Blood Care GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-026-03994-7","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:54:25Z","timestamp":1782143665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of leukocyte depletion filters for the removal of EpCAM-positive tumor cells during oncologic intraoperative blood salvage using CATUVAB\u00ae: an exploratory feasibility study"],"prefix":"10.1186","volume":"26","author":[{"given":"Simon","family":"Mathis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Putzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schnegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Aniorte Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Lindhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"9","key":"3994_CR1","first-page":"CD001888","volume":"9","author":"TD Lloyd","year":"2023","unstructured":"Lloyd TD, Geneen LJ, Bernhardt K, McClune W, Fernquest SJ, Brown T, et al. Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery. Cochrane Database Syst Rev. 2023;9(9):CD001888.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3994_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11605-019-04374-y","volume":"24","author":"SM Frank","year":"2020","unstructured":"Frank SM, Sikorski RA, Konig G, Tsilimigras DI, Hartmann J, Popovsky MA, et al. Clinical utility of autologous salvaged blood: a review. J Gastrointest Surg. 2020;24(2):464\u201372.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"3994_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1213\/01.ane.0000258039.79028.7c","volume":"104","author":"JR Waters","year":"2007","unstructured":"Waters JR, Meier HH, Waters JH. An economic analysis of costs associated with development of a cell salvage program. Anesth Analg. 2007;104(4):869\u201375.","journal-title":"Anesth Analg"},{"issue":"6","key":"3994_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","volume":"34","author":"SA Kozek-Langenecker","year":"2016","unstructured":"Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2016;34(6):332\u201395.","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"3994_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/jcp.2011.090274","volume":"64","author":"G Spizzo","year":"2011","unstructured":"Spizzo G, Fong D, Wurm M, Ensinger C, Obrist P, Hofer C, et al. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. J Clin Pathol. 2011;64(5):415\u201320.","journal-title":"J Clin Pathol"},{"issue":"3","key":"3994_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000475060","volume":"28","author":"J Zorzos","year":"1995","unstructured":"Zorzos J, Zizi A, Bakiras A, Pectasidis D, Skarlos DV, Zorzos H, et al. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study. Eur Urol. 1995;28(3):251\u20134.","journal-title":"Eur Urol"},{"issue":"3","key":"3994_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bjc.6603881","volume":"97","author":"P Ruf","year":"2007","unstructured":"Ruf P, Gires O, Jager M, Fellinger K, Atz J, Lindhofer H. Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. Br J Cancer. 2007;97(3):315\u201321.","journal-title":"Br J Cancer"},{"issue":"2","key":"3994_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1054\/bjoc.2000.1237","volume":"83","author":"R Zeidler","year":"2000","unstructured":"Zeidler R, Mysliwietz J, Csanady M, Walz A, Ziegler I, Schmitt B, et al. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells. Br J Cancer. 2000;83(2):261\u20136.","journal-title":"Br J Cancer"},{"key":"3994_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-642-20910-9_16","volume-title":"Bispecific antibodies","author":"H Lindhofer","year":"2011","unstructured":"Lindhofer H, Hess J, Ruf P. Trifunctional Triomab\u00ae antibodies for cancer therapy. In: Bispecific antibodies. Springer; 2011. p. 289\u2013312."},{"issue":"1","key":"3994_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12871-021-01479-3","volume":"21","author":"A Winter","year":"2021","unstructured":"Winter A, Zacharowski K, Meybohm P, Schnitzbauer A, Ruf P, Kellermann C, et al. Removal of EpCAM-positive tumor cells from blood collected during major oncological surgery using the Catuvab device- a pilot study. BMC Anesthesiol. 2021;21(1):261.","journal-title":"BMC Anesthesiol"},{"key":"3994_CR11","doi-asserted-by":"publisher","first-page":"111972","DOI":"10.1016\/j.jclinane.2025.111972","volume":"106","author":"P Meybohm","year":"2025","unstructured":"Meybohm P, Choorapoikayil S, Zinn S, Lindau S, Heiss M, Defosse J, et al. Removal of EpCAM-positive tumor cells during intraoperative blood salvage- A pivotal multicenter clinical study (REMOVE). J Clin Anesth. 2025;106:111972.","journal-title":"J Clin Anesth"},{"issue":"12","key":"3994_CR12","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.3390\/jcm12124088","volume":"12","author":"L Merolle","year":"2023","unstructured":"Merolle L, Schiroli D, Farioli D, Razzoli A, Gavioli G, Iori M, et al. Reduction of EpCAM-positive cells from a cell salvage product is achieved by leucocyte depletion filters alone. J Clin Med. 2023;12(12):4088.","journal-title":"J Clin Med"},{"issue":"9","key":"3994_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/anae.14331","volume":"73","author":"AA Klein","year":"2018","unstructured":"Klein AA, Bailey CR, Charlton AJ, Evans E, Guckian-Fisher M, McCrossan R, et al. Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia. 2018;73(9):1141\u201350.","journal-title":"Anaesthesia"},{"key":"3994_CR14","unstructured":"Bundes\u00e4rztekammer: Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten: mit 19 Tabellen: Deutscher \u00c4rzteverlag; 2009."},{"issue":"4","key":"3994_CR15","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/hep.26151","volume":"57","author":"YF Sun","year":"2013","unstructured":"Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology. 2013;57(4):1458\u201368.","journal-title":"Hepatology"},{"issue":"8","key":"3994_CR16","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/cells9081836","volume":"9","author":"SZ Eslami","year":"2020","unstructured":"Eslami SZ, Cortes-Hernandez LE, Alix-Panabieres C. Epithelial cell adhesion molecule: an anchor to isolate clinically relevant circulating tumor cells. Cells. 2020;9(8):1836.","journal-title":"Cells"},{"issue":"10","key":"3994_CR17","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.3390\/ijms26104740","volume":"26","author":"K Sawai","year":"2025","unstructured":"Sawai K, Koneri K, Kimura Y, Goi T. CD133 expression in circulating tumor cells as a prognostic marker in colorectal cancer. Int J Mol Sci. 2025;26(10):4740.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3994_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4161\/cam.18953","volume":"6","author":"S Imrich","year":"2012","unstructured":"Imrich S, Hachmeister M, Gires O. EpCAM and its potential role in tumor-initiating cells. Cell Adh Migr. 2012;6(1):30\u20138.","journal-title":"Cell Adh Migr"},{"issue":"6","key":"3994_CR19","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","volume":"14","author":"BE Lippitz","year":"2013","unstructured":"Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218-228.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3994_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.aat.2015.03.002","volume":"53","author":"CH Hsing","year":"2015","unstructured":"Hsing CH, Wang JJ. Clinical implication of perioperative inflammatory cytokine alteration. Acta Anaesthesiol Taiwan. 2015;53(1):23\u20138.","journal-title":"Acta Anaesthesiol Taiwan"},{"issue":"2","key":"3994_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.athoracsur.2006.09.041","volume":"83","author":"SJ Allen","year":"2007","unstructured":"Allen SJ, McBride WT, McMurray TJ, Phillips AS, Penugonda SP, Campalani G, et al. Cell salvage alters the systemic inflammatory response after off-pump coronary artery bypass grafting surgery. Ann Thorac Surg. 2007;83(2):578\u201385.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3994_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.athoracsur.2010.02.003","volume":"89","author":"S Damgaard","year":"2010","unstructured":"Damgaard S, Nielsen CH, Andersen LW, Bendtzen K, Tvede M, Steinbr\u00fcchel DA. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Ann Thorac Surg. 2010;89(5):1511\u20137.","journal-title":"Ann Thorac Surg"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-03994-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-03994-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-03994-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:03:13Z","timestamp":1788523393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-026-03994-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3994"],"URL":"https:\/\/doi.org\/10.1186\/s12871-026-03994-7","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Medical University of Innsbruck (approval number 1454\/2021) and conducted in accordance with the Declarations of Helsinki. Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Horst Lindhofer: shares in or honoraria from the company making the medical device. Peter Ruf, Claudia Kellermann: Employees of Trion Research GmbH, Zeppelinstr. 4, 82178 Puchheim, Germany. Horst Lindhofer, Jonas Aniorte Jimenez: Employees of Lindis Blood Care GmbH, Neuendorfstrasse 18b, 16761 Henningsdorf, Germany.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"548"}}